Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
FDA approves Tula system for recurrent pediatric ear infections
- Author:
- Christopher Palmer
The device can be used under local anesthesia in an office setting instead of a hospital setting with general anesthesia.
News
Blunted ventral striatal responses found in remitted bipolar I
- Author:
- Christopher Palmer
The current findings imply that, in individuals with bipolar disorder, individual differences in [positive urgency measure] may also help account...
News
Chronic pain more common in women with ADHD or ASD
- Author:
- Christopher Palmer
Treating patients’ ADHD helps to reduce the pain in some cases, researchers report.
News
FDA still concerned about biotin affecting troponin tests
- Author:
- Christopher Palmer
The agency has issued an update to its 2017 safety communication.
News
Resting-state cerebral blood flow tied to apathy in schizophrenia
- Author:
- Christopher Palmer
“The paucity of reported associations between striatal rCBF and negative symptoms could result from the fact that until now apathy and diminished...
News
Emotional processing of scenes in bipolar I appears intact
- Author:
- Christopher Palmer
“Future research ... should focus on neurocognitive subtypes of mood and psychotic disorders, [and] other domains of emotional responding and...
News
Six strengths identified in adult men with ADHD
- Author:
- Christopher Palmer
Results from a small qualitative investigation are based on interviews with high-functioning participants.
News
Religious vaccination exemptions may be personal belief exemptions in disguise
- Author:
- Christopher Palmer
A new study examines how rates of religious exemptions for vaccination differ when personal belief exemptions are available and what happens when...
News
COGS update shows viability of endophenotypes in schizophrenia research
- Author:
- Christopher Palmer
"As stable biomarkers of the underlying brain dysfunctions, endophenotypes hold promise for parsing clinical heterogeneity of schizophrenia and...
News
FDA approves onabotulinumtoxinA for pediatric lower limb spasticity
- Author:
- Christopher Palmer
The indication excludes spasticity related to cerebral palsy.
News
FDA approves ustekinumab for ulcerative colitis
- Author:
- Christopher Palmer
This indication for moderate to severe ulcerative colitis is the fourth the therapy has received since it was first approved by the FDA in 2009....
News
Duloxetine ‘sprinkle’ launches for patients with difficulty swallowing
- Author:
- Christopher Palmer
Difficulty swallowing is believed to affect 30%-35% of long-term care residents.
News
FDA approves transdermal asenapine system for schizophrenia
- Author:
- Christopher Palmer
This approval marks the first transdermal patch formulation of an antipsychotic for treatment of schizophrenia.
News
Schizophrenia patients have ‘aberrant’ response to Epstein-Barr
- Author:
- Christopher Palmer
Individuals with schizophrenia appear to express atypical proportions of antibodies to the virus.
News
Patients with nonaffective psychosis offer treatment target preferences
- Author:
- Christopher Palmer
Most of the patients wanted at least one of the eight problem areas assessed in the study treated, and on average, they wanted more than four...